Related Experiment Video
Updated: Sep 20, 2025

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
The causal effects of primary biliary cholangitis on irritable bowel syndrome: a mendelian randomization study
Jinwei Niu1, Guochao Zhang, Wu Ning
1Department of General Surgery, China-Japan Friendship Hospital, Beijing, China.
Background:
The gut-liver axis indicates a potential relationship between the primary biliary cholangitis (PBC) and irritable bowel syndrome (IBS). Nonetheless, the causality of this association remains unclear. This study performed a two-sample Mendelian randomization (MR) approach to investigate the causal relationship between the PBC and IBS.
Methods:
We used public genome-wide association study (GWAS) datasets for PBC and IBS, treating PBC as the exposure and IBS as the outcome, in an MR analysis primarily employing the inverse-variance weighted (IVW) method. Sensitivity analyses and pleiotropy/heterogeneity tests were conducted to ensure finding robustness, validating trait-specific genetic associations and consistent variant effects, enhancing study credibility.
Results:
Findings encompassed the selection of 15 valid instrumental variables (IVs) for PBC and 18 for IBS. The MR analyses uncovered a statistically significant link, suggesting that PBC is positively correlated with an increased likelihood of IBS development (IVW odds ratio: 1.010887; 95% confidence interval: 1.0004241 to 1.021459; P -value = 0.04136). Deeper investigation through MR-Egger regression analysis indicated negligible probability of result distortion due to directional pleiotropy (regression intercept: 0.001207003; P -value = 0.7193585). Consistency was further corroborated by Cochran's Q test and funnel plot inspections, which displayed no signs of heterogeneity ( P = 0.5410849) or asymmetry, reinforcing the absence of detrimental pleiotropic influences.
Conclusions:
Our study provides evidence of a potential causal link between PBC and increased IBS risk, highlighting the need for further research to explore the mechanisms underlying this complex disease relationship.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Constipation-Predominant IBS

